AI Pioneers New Antibiotic Targets for IBD, Predicting Mechanisms Ahead of Experimental Validation
Researchers from McMaster University and the Massachusetts Institute of Technology (MIT) have hit a remarkable milestone by discovering a new antibiotic named enterololin, specifically engineered...